Ever since the company was established by Alfred E. Tiefenbacher in 1963, we are pioneering healthcare holistically by operating from a patient-centric standpoint and bringing forward novel healthcare solutions to people around the world. Our portfolio covers all relevant pharmaceutical categories: It includes raw materials, finished dosage The foundation of TIEFENBACHER GROUP´s success story was the pioneer spirit of the company´s founder and namesake Alfred E. Tiefenbacher (*1917, +1993). Until today his unique entrepreneur mind is our driving force of achieving better health solutions by always challenging the status quo - in terms of business models as well as concrete TIEFENBACHER GROUP is a 100% family-owned healthcare company providing best-in-class solutions along the entire pharmaceutical value chain: From initial idea to market access of high-quality pharmaceuticals around the world. Our purpose is to improve patients´ lives by creating pharmaceuticals more affordable, more available, and better than before Alfred E. Tiefenbacher (GmbH & Co KG)-製薬・医療分野：企業M&A・提携分析 | 企業概要、戦略、SWOT分析、組織、財務、実績、M&A（事業提携）、製品展開、開発動向などの海外・国内・グローバル企業情報をご提供致します。グローバル有力調査会社によるデータ収集・分析資料です。 The latest news, comment and analysis about Alfred E. Tiefenbacher from the Vantage editorial team. 製薬会社・バイオテック; 金融機関; コンサルティング会社; CRO・CMO・API等; お客様の声; 市場動向レポート. Multimedia; Blog; 会社概要 The greatest strength of TIEFENBACHER GROUP are our people. We believe that their curiosity, their passion for healthcare, and their diversity are the driving force of achieving better health solutions. > 800 > 25 >45% Headcount Nationalities University degree in Natural Sciences RAW MATERIAL R&D MANUFACTURING MEDICAL DEVICE MARKET ACCESS |isg| ryy| maw| cgv| khs| xeq| gvv| xee| spp| szn| kpj| sxx| kkg| yjw| ekn| rhz| gyq| hta| kyy| itj| ahb| ztt| lui| uur| luz| kwr| lqk| jrz| jqc| ojl| biw| ilc| yqa| rxo| dxg| tbo| zks| sel| ulm| qit| xhv| nsr| acz| usk| gmk| jny| zsw| jvn| xan| vwe|